ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
PureTech Health PLC

PureTech Health PLC (PRTC)

27.8892
-0.6108
(-2.14%)
Closed May 01 4:00PM
27.8892
0.00
(0.00%)
After Hours: 4:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
27.8892
Bid
15.00
Ask
43.23
Volume
458
27.25 Day's Range 28.01
0.00 52 Week Range 0.00
Market Cap
Previous Close
28.50
Open
28.01
Last Trade
2
@
27.04
Last Trade Time
Financial Volume
$ 12,805
VWAP
27.958
Average Volume (3m)
-
Shares Outstanding
278,566,000
Dividend Yield
-
PE Ratio
-11.95
Earnings Per Share (EPS)
-0.18
Revenue
23.75M
Net Profit
-50.35M

About PureTech Health PLC

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines ... PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, neurological & neuropsychological disorders, among others. It operates in following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept, focused on addressing some of society's healthcare needs. Show more

Sector
Home Health Care Services
Industry
Home Health Care Services
Headquarters
London, Gbr
Founded
1970
PureTech Health PLC is listed in the Home Health Care Services sector of the NASDAQ with ticker PRTC. The last closing price for PureTech Health was $28.50. Over the last year, PureTech Health shares have traded in a share price range of $ 0.00 to $ 0.00.

PureTech Health currently has 278,566,000 shares outstanding. The market capitalization of PureTech Health is $601.70 million. PureTech Health has a price to earnings ratio (PE ratio) of -11.95.

PRTC Latest News

PureTech Announces Annual Results for Year Ended December 31, 2023

Significant operational and clinical progress in 2023 and early 2024 with maturation of Internal Programs,1 launch of two new Founded Entities,2 including a $100 million Series A financing for...

PureTech Health: Notice of Results

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") plans to publish its Annual Report and Accounts and financial results for the year ended December 31, 2023, on...

PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis

Topline results are expected in Q4 2024 PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of...

PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers

LYT-200 is being evaluated in locally advanced/metastatic solid tumors, including head and neck cancers, as well as in hematological malignancies, such as acute myeloid leukemia and high-risk...

PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions

Bharatt Chowrira, Ph.D., J.D., named Chief Executive Officer of PureTech; PureTech Co-founder, Eric Elenko, Ph.D., promoted to President PureTech Founding Chief Executive Officer, Daphne Zohar...

PureTech Proposes $100 Million Capital Return

Proposed capital return of $100 million by way of a Tender Offer at 250 pence per Ordinary Share Premium of 25% to PureTech’s trailing three-day VWAP Proposed Tender Offer follows completion of...

Bristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 Billion

Acquisition centered on KarXT, which was invented at PureTech, as a potential first-in-class treatment for schizophrenia in adults PureTech to receive approximately $293 million gross proceeds...

PureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid Leukemia

LYT-200 is being advanced in hematological malignancies such as acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS), and locally advanced/metastatic solid tumors, including...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CGCCanopy Growth Corporation
$ 14.89
(78.97%)
83.58M
AKLIAkili Inc
$ 0.39
(66.03%)
86.48M
GVVisionary Holdings Inc
$ 0.256
(60.00%)
2.18M
GMMGlobal Mofy Metaverse Ltd
$ 1.47
(58.01%)
80.37M
IMCCIM Cannabis Corporation
$ 0.88
(57.14%)
13.14M
CETXCemtrex Inc
$ 1.1499
(-35.40%)
575.64k
LICNLichen China Limited
$ 1.32
(-34.98%)
1.28M
BCLIBrainstorm Cell Therapeutics Inc
$ 0.3731
(-30.86%)
1.74M
NRXPNRX Pharmaceuticals Inc
$ 2.60
(-26.76%)
937.63k
HWHHWH International Inc
$ 1.92
(-25.58%)
3.96M
TLRYTilray Brands Inc
$ 2.475
(39.83%)
154.33M
SQQQProShares UltraPro Short QQQ
$ 11.95
(5.66%)
129.32M
TSLATesla Inc
$ 183.28
(-5.55%)
127.04M
JAGXJaguar Health Inc
$ 0.2146
(3.17%)
100.27M
EGOXNext e GO NV
$ 0.0307
(11.23%)
95.14M

Discussion

View Full Feed
pepeoil pepeoil 4 minutes ago
This chit isn’t going anywhere
UNRG
pepeoil pepeoil 5 minutes ago
Loaded more of these cheapies man,
XOM
pepeoil pepeoil 6 minutes ago
My only winner of the day. Lol. I love this stock but hate the company.
PGR
dale1953 dale1953 6 minutes ago
That site is run by Anthony Powers, who is paid by a lot of the mining companies. Since Marathon is not 1 of his sponsors, his views towards MARA are usually not that great. If you click on that link then you will see a list of the companies that he says trust his analysis. Marathon is not on the l
MARA
NotSure2 NotSure2 9 minutes ago
Surely do, more than you:

In 2023 you kept saying "soon" "soon" "soon"... multiple times about SP going to the moon , shareholders will be "millionaires" etc...

-You are claiming NWBO submit for whatever combo, not DCVAX-L. (when they clearly PR ed DCVax-L).
NWBO
Ppastis Ppastis 12 minutes ago
Well said !!!!
This ‘ thing ‘ is a disgrace for this board !!!
Moderator time for action !
LWLG
fuagf fuagf 14 minutes ago
rooster, I know your SCOTUS said it was ok to lie in public, that doesn't mean
we're gonna let you lie here as much as you have today. Get the message.
RuudSaltis RuudSaltis 16 minutes ago
I think that your post is offensive and discriminating. Please remove this poster and put him on the bench for long. Many poster have been punished for less!
LWLG
VST7 VST7 20 minutes ago
They will Dump til there's NO BID..Then do a Massive Reverse Split...

I would Not Buy/Hold ANY of this POS...
MJLB
dstock07734 dstock07734 22 minutes ago
beartrap12,
Thanks for the post.

My speculation is that the approval could be about DCVax-L + poly-iclc based on RWD/RWE with guidance about the combination concerning keytruda. There is no SEC requirement about public disclosure of drug application. I suspect the approval shou
NWBO
littlejohn littlejohn 23 minutes ago
SBUX seemed to have a solid miss...

https://stocktwits.com/wallstengine/message/571333945

Question isn't the economy...

How does a coffee selling company

miss in a winter quarter?...

Too many working and not enough to
joev2 joev2 23 minutes ago
https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=318274217&type=HTML&symbol=SINT&cdn=9f52f4cba97f149e09d7019a4a363463&companyName=SiNtx+Technologies+Inc.&formType=8-K&formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&dateFiled=2024-04-30
SINT
CoinOp CoinOp 27 minutes ago
I have discovered you have not done much DD on EBET, you can't even follow the lawsuit stages we are in .

Last Docket #59 was on 4/11, it was also the first Docket that needed to be sealed, no more motions out there left pending to delay going to trial , which means DISCOVERY phase c
EBET
Dodger1 Dodger1 33 minutes ago
$AABB

GO AABB!
AABB
DR_rugby DR_rugby 35 minutes ago
And full access to the IRS tax code

Write downs

https://m.youtube.com/watch?v=hSy8kIF8Plg

The ground is shifting right under our feet

Also

MJ is a cash heavy industry that when changes happens

They can dep
SNDL
236T568 236T568 41 minutes ago
Read this

https://twitter.com/DrEricDing/status/1785359897497845794?s=19
littlejohn littlejohn 43 minutes ago
SMCI has Ai related products for NVDA, AMD,

and INTC...

https://www.supermicro.com/en/solutions/ai-deep-learning

click on GPU Optimized Systems to

review closer...

Liquid cooled options add to choices...

Interd
AMD INTC NVDA
Buellersback Buellersback 44 minutes ago
UNSS was one of my best financially rewarding stocks, despite its unfortunate demise. I guess you haven't learned the concept of taking profits, yet . No wonder you seem lost and bitter. You might want to stick to mutual funds 😂
RGLG
DR_rugby DR_rugby 45 minutes ago
Sam let’s chat

https://m.youtube.com/watch?v=ISDgcB-J4fQ

Margin calls coming

GLTA
GME
beartrap12 beartrap12 45 minutes ago
It seems to me at minimum the approval is about DCVax-L combined with poly-iclc. stock

dstock, Others have suggested that DCVax-L needs to be approved on it's own merit before being approved together with Poly ICLC.I suggested that perhaps MHRA will do both at this expected upcoming a
NWBO
boston745 boston745 47 minutes ago
Nope. Less tech not more. Tech will be our downfall.
TSLA

Your Recent History

Delayed Upgrade Clock